DD209624A5 - Verfahren zur herstellung von benzimidazolverbindungen - Google Patents
Verfahren zur herstellung von benzimidazolverbindungen Download PDFInfo
- Publication number
- DD209624A5 DD209624A5 DD83249690A DD24969083A DD209624A5 DD 209624 A5 DD209624 A5 DD 209624A5 DD 83249690 A DD83249690 A DD 83249690A DD 24969083 A DD24969083 A DD 24969083A DD 209624 A5 DD209624 A5 DD 209624A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- benzimidazole
- amino
- formula
- compounds
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/366,760 US4420479A (en) | 1982-04-08 | 1982-04-08 | Olefinic benzimidazoles, formulations, and antiviral methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD209624A5 true DD209624A5 (de) | 1984-05-16 |
Family
ID=23444387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD83249690A DD209624A5 (de) | 1982-04-08 | 1983-04-08 | Verfahren zur herstellung von benzimidazolverbindungen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4420479A (cs) |
| EP (1) | EP0091795A1 (cs) |
| KR (1) | KR840004409A (cs) |
| AU (1) | AU1322483A (cs) |
| CA (1) | CA1197245A (cs) |
| DD (1) | DD209624A5 (cs) |
| DK (1) | DK152883A (cs) |
| ES (2) | ES521318A0 (cs) |
| FI (1) | FI831191A7 (cs) |
| GB (1) | GB2119789B (cs) |
| GR (1) | GR78168B (cs) |
| IL (1) | IL68299A0 (cs) |
| NZ (1) | NZ203798A (cs) |
| PH (1) | PH18108A (cs) |
| PL (3) | PL247909A1 (cs) |
| PT (1) | PT76499B (cs) |
| RO (1) | RO86319B (cs) |
| ZA (1) | ZA832410B (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0494405B2 (en) * | 1991-01-10 | 2000-04-19 | Transcend Therapeutics, Inc. | Use of L-2-oxo thiazolidine-4-carboxylate for the treatment of pulmonary diseases |
| US5747459A (en) * | 1991-02-04 | 1998-05-05 | Nestec, Ltd. | Method for insuring adequate intracellular glutathione in tissue |
| US5430045A (en) * | 1992-04-23 | 1995-07-04 | Free Radical Sciences, Inc. | Method of reducing or preventing bone marrow hypoplasia |
| US5605919A (en) * | 1993-02-26 | 1997-02-25 | Takeda Chemical Industries, Ltd. | Treatment for viral diseases |
| US5447712A (en) * | 1993-12-09 | 1995-09-05 | Free Radical Sciences | Method of reducing cyclophosphamide induced hemorrhagic cystitis |
| US5475109A (en) * | 1994-10-17 | 1995-12-12 | Merck & Co., Inc. | Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease |
| US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
| US5545653A (en) * | 1995-06-07 | 1996-08-13 | Eli Lilly And Company | Anti-viral compounds |
| JP2000511899A (ja) * | 1996-06-05 | 2000-09-12 | イーライ・リリー・アンド・カンパニー | 抗―ウイルス性化合物群 |
| US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
| US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
| KR100539030B1 (ko) | 1996-08-12 | 2005-12-27 | 셀진 코포레이션 | 면역치료제 및 이를 이용하여 사이토카인 농도를 감소시키는 방법 |
| AU6031898A (en) * | 1997-01-22 | 1998-08-07 | Eli Lilly And Company | Anti-viral compounds |
| EP1001767A4 (en) * | 1997-06-04 | 2001-07-04 | Lilly Co Eli | ANTIVIRAL CONNECTIONS |
| NZ542407A (en) | 2003-03-05 | 2008-08-29 | Celgene Corp | Diphenylethylene compounds and uses thereof |
| US7470723B2 (en) | 2003-03-05 | 2008-12-30 | Celgene Corporation | Diphenylethylene compounds and uses thereof |
| JP2008512378A (ja) | 2004-09-03 | 2008-04-24 | セルジーン・コーポレーション | 置換複素環式化合物及びその使用 |
| CN108997158B (zh) * | 2018-07-16 | 2020-12-15 | 青岛科技大学 | 一种实现二取代酰胺与二苯基甲酮偶联的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018790A (en) * | 1975-05-08 | 1977-04-19 | Eli Lilly And Company | Substituted 1-sulfonylbenzimidazoles |
| US4174454A (en) * | 1975-08-28 | 1979-11-13 | Eli Lilly And Company | Alkylidenylmethyl-substituted 1-sulfonylbenzimidazoles |
| NZ181789A (en) * | 1975-08-28 | 1979-01-11 | Lilly Co Eli | 5(6)-substituted-1-hydrocarbylulphanyl-2-amino-bezimidazoles |
| CA1076582A (en) * | 1975-10-28 | 1980-04-29 | Charles J. Paget | Antiviral thiazolinyl or thiazinyl ketobenzimidazoles |
| US4008243A (en) * | 1975-11-19 | 1977-02-15 | Eli Lilly And Company | Antiviral thiazolinyl or thiazinyl benzimidazole esters |
| US4118573A (en) * | 1975-11-24 | 1978-10-03 | Eli Lilly And Company | Substituted 1-sulfonylbenzimidazoles |
| ZA77691B (en) * | 1976-12-15 | 1978-09-27 | Lilly Co Eli | Novel 1-sulfonyl-5(6)-substituted-benzimidazoles |
| US4230868A (en) * | 1979-04-17 | 1980-10-28 | Eli Lilly And Company | α-Alkyl-α-hydroxybenzyl-substituted 1-sulfonylbenzimidazoles |
| US4316021A (en) * | 1979-08-13 | 1982-02-16 | Eli Lilly And Company | Substituted 1-sulfonylbenzimidazoles |
-
1982
- 1982-04-08 US US06/366,760 patent/US4420479A/en not_active Expired - Lifetime
-
1983
- 1983-04-05 PT PT76499A patent/PT76499B/pt unknown
- 1983-04-05 ZA ZA832410A patent/ZA832410B/xx unknown
- 1983-04-05 IL IL68299A patent/IL68299A0/xx unknown
- 1983-04-05 PH PH28738A patent/PH18108A/en unknown
- 1983-04-06 CA CA000425307A patent/CA1197245A/en not_active Expired
- 1983-04-06 DK DK152883A patent/DK152883A/da not_active IP Right Cessation
- 1983-04-06 KR KR1019830001417A patent/KR840004409A/ko not_active Ceased
- 1983-04-06 NZ NZ203798A patent/NZ203798A/en unknown
- 1983-04-06 GR GR71005A patent/GR78168B/el unknown
- 1983-04-06 RO RO110574A patent/RO86319B/ro unknown
- 1983-04-07 GB GB08309388A patent/GB2119789B/en not_active Expired
- 1983-04-07 ES ES521318A patent/ES521318A0/es active Granted
- 1983-04-07 AU AU13224/83A patent/AU1322483A/en not_active Abandoned
- 1983-04-07 EP EP83301976A patent/EP0091795A1/en not_active Ceased
- 1983-04-07 PL PL24790983A patent/PL247909A1/xx unknown
- 1983-04-07 PL PL24790883A patent/PL247908A1/xx unknown
- 1983-04-07 PL PL24138583A patent/PL241385A1/xx unknown
- 1983-04-08 FI FI831191A patent/FI831191A7/fi not_active Application Discontinuation
- 1983-04-08 DD DD83249690A patent/DD209624A5/de unknown
-
1984
- 1984-07-11 ES ES534218A patent/ES8505966A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US4420479A (en) | 1983-12-13 |
| ES8502097A1 (es) | 1984-12-16 |
| PT76499B (en) | 1986-03-18 |
| KR840004409A (ko) | 1984-10-15 |
| ES534218A0 (es) | 1985-06-01 |
| GB2119789B (en) | 1985-08-29 |
| IL68299A0 (en) | 1983-07-31 |
| GR78168B (cs) | 1984-09-26 |
| PH18108A (en) | 1985-03-22 |
| AU1322483A (en) | 1983-10-13 |
| PT76499A (en) | 1983-05-01 |
| DK152883D0 (da) | 1983-04-06 |
| ZA832410B (en) | 1984-11-28 |
| FI831191L (fi) | 1983-10-09 |
| FI831191A7 (fi) | 1983-10-09 |
| ES8505966A1 (es) | 1985-06-01 |
| DK152883A (da) | 1983-10-09 |
| PL247908A1 (en) | 1985-01-16 |
| EP0091795A1 (en) | 1983-10-19 |
| FI831191A0 (fi) | 1983-04-08 |
| GB2119789A (en) | 1983-11-23 |
| PL241385A1 (en) | 1984-09-24 |
| ES521318A0 (es) | 1984-12-16 |
| NZ203798A (en) | 1985-07-12 |
| RO86319A (ro) | 1985-03-15 |
| PL247909A1 (en) | 1984-12-17 |
| CA1197245A (en) | 1985-11-26 |
| RO86319B (ro) | 1985-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD209624A5 (de) | Verfahren zur herstellung von benzimidazolverbindungen | |
| DE3881443T2 (de) | Imidazol-Verbindung und diese enthaltende biozide Zusammensetzungen. | |
| DE69429827T2 (de) | Plättchen aktivierender faktor (paf)-antagonist: imidazopyridin - indole | |
| DE69128481T2 (de) | Antivirale und antihypertensive verbindungen | |
| DE60015296T2 (de) | Indolderivate und ihre verwendung als mcp-1 rezeptor antagonisten | |
| DE69118388T2 (de) | Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung | |
| DE69906940T2 (de) | Bizyclische pyrrolverbindungen, deren pharmazeutische zusammensetzungen und ihre verwendung als entzündungshemmende und immunmodulierende mittel | |
| DE3873127T2 (de) | Therapeutische praeparate. | |
| DE69110254T2 (de) | Hydroxychinolonderivate. | |
| DE69730837T2 (de) | Indolderivate zur behandlung von osteoporose | |
| WO2008003378A1 (de) | Sulfamat-benzothiophen-derivate | |
| DE69533194T2 (de) | PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN | |
| DE69112074T2 (de) | Disubstituierte arylverbindungen welche eine selektive leukotrien-b4 antagonistische aktivität aufweisen. | |
| WO2001070687A1 (de) | Indole zur behandlung von krankheiten die mit schilddrüsenhormonen behandeln werden können | |
| EP1003724B1 (de) | Substituierte-chinolin-derivate mit antiviraler wirkung | |
| EP0161599A2 (de) | Neue Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| EP0043788A1 (de) | Neue Imidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| EP0539329A1 (de) | Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten | |
| DE69734594T2 (de) | Nmda (n-methyl-d-aspartate) antagonists | |
| DD291551A5 (de) | Verfahren zur herstellung von substituierten hydroxamsaeurederivaten | |
| EP0455596B1 (de) | Substituierte Indole | |
| EP0072961B1 (de) | 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2645865A1 (de) | 5-methoxy-6-halogentryptamine und verfahren zu ihrer herstellung | |
| DE69422629T2 (de) | Indolderivate als 5-alpha-reductase-1 inhibitoren | |
| EP0304624A2 (de) | Benzimidazol-2-yl-pyridiniumverbindungen |